A novel gene targeting strategy, small fragment homologous replacement (SFHR), has been used to correct specific genomic lesions in human epithelial cells. The frequency of targeting was estimated to be 1-10%. However, given the genomic target, the cystic fibrosis transmembrane conductance regulator (CFTR) gene, it is difficult to accurately quantify targeting frequency. As an alternative to targeting CFTR, targeted correction of a mutant selectable marker or reporter gene would be more amenable to accurate and rapid quantification of gene targeting efficiency. The present study evaluates the conditions that modulate SFHR-mediated correction of a defective Zeocin antibiotic resistance (Zea') gene that has been inactivated by a 4-bp insertion. The condi tions include delivery systems, plasmid-to-fragment ratio, fragment length, and fragment strand edness (single-or double-stranded DNA). Targeting fragments comprise the wild-type Zea' gene sequence and were either 410 (Zeo1) or 458 bp (Zeo3). Expression vectors containing the corrected Zeo r gene were isolated as episomal plasmids or were allowed to stably integrate into cultured human airway epithelial cells. Correction of the Zeo r gene was phenotypically defined as restora tion of resistance to Zeocin in either bacteria or epithelial cell clones. Extrachromosomal gene correction was assayed using polymerase chain reaction amplification, restriction enzyme diges tion, DNA sequencing, and Southern blot hybridization analysis of DNA from isolated prokaryotic and eukaryotic clones. Neither random sequence alteration in the target episomal gene nor random integration of the small fragments was detected. Targeted correction efficiencies of up to 4% were attained. These studies provide insight into parameters that can be modulated for the optimization of SFHR-mediated targeting.
INTRODUCTION
egies used to introduce the targeting DNA into cells mit igate the immune and inflammatory side-effects triggered by viral capsid antigens and unmethylated CpG se quences present in cDNA expression plasmids (5) (6) (7) .
Gene targeting, as a strategy for gene therapy, provides a mechanism for achieving permanent. site-specific correc tion of DNA lesions and results in the cell-appropriate expression of the target gene (1, 2) . A gene targeting strategy allows the integrity and regulation of the gene to be maintained even when cis-acting regulatory elements are distant from the coding sequences (3) or are within introns (4) . In addition, the nonviral gene delivery strat-Z3 Z'1 [--r. mutation. As a result, wtCFTR mRNA expression and the functional correction of the cAMP-dependent c1-trans port defect associated with CF were observed (8) . A tar geting frequency of 1-10% was indicated in this study. In a parallel study, targeting DNA fragments comprising genomic 6F508 CFTR sequence (488 bp) were able to delete the 3 nt that constitute the 6F508 mutation gene in the genomic DNA of normal human airway epithelial cells (10) . Furthermore, a single nucleotide, -100 bp up stream of the 6F508 mutation, was concomitantly altered to introduce a novel restriction enzyme cleavage site for analysis.
Zeo3 fragment 458 bp
For the successful application of SFHR as a gene ther apy, optimization of the conditions for targeting is necessary. A drawback of having CFTR as the target gene is the lack of an endogenous selection mechanism that readily differentiates between targeted and paren tal cells and, thus, limits the ability to accurately quan tify targeting frequency. As an alternative, a gene that is either critical for cell survival or makes a readily detect able protein product can be used. Transient transfec tion assays, employing expression vectors carrying functionally defective selectable marker or reporter MOLECULAR THERAPY Vol. 3, No. 2, February 2001 Copyright © The American Society of Gene Therapy genes, have been valuable for assaying targeting fre quencies in other sequence-specific correction studies (12) (13) (14) (15) (16) . Because the episomal vectors are not inte grated, they can be isolated from the transfected cells and used to transform bacteria for a quantitative assess ment of targeting frequency. This type of quantitative assessment is critical for the optimization of parameters that modulate SFHR efficacy.
In the present study, the frequency of SFHR-mediated correction was used as a means to evaluate those condi tions that can enhance the effectiveness of SFHR in hu man epithelial cells. The defective Zeocin antibiotic resis tance gene (Zeo'), in a prokaryotic/eukaryotic expression vector, was cotransfected with small fragments of wild type Zea' DNA into transformed CF airway epithelial cells ( Fig. 1 ). SFHR-mediated correction was determined as res toration of Zeocin resistance after transient transfection and stable transfections in eukaryotic (human epithelial) cells. In addition, both prokaryotic and eukaryotic Zeo cin-resistant clones were characterized by restriction en zyme digestion, direct DNA sequencing, and Southern blot hybridization.
MATERIALS AND METHODS
Cells. SV40-transformed (17) cystic fibrosis bronchial epithelial cells (CFBE4lo-), homozygous for the 6F508 CFfR mutation (unpublished data), were used. Cells were grown in Eagle's minimal essential medium (MEM) supplemented with 10% fetal bovine serum, 2 mM 1-glutaminc, 1 % penicillin/streptomycin, at 37°C in 5% C0,-95% air. All the cultures were maintained in flasks or dishes precoated with an extracellular matrix of fibronectin-Vitrogenbovine serum albumin (I 8). ElectroMax Escherid1ia coli DH10B (Rec Al -) cells (Life Technologies, CA) were used for the bacterial transformation studies.
Plasmid construction. The plasmid pZamp was constructed by introduc ing the ampicillin gene from pcDNA3 (lnvitrogen, CA) (fragment Sa/1-PvuII) into the multiple cloning site of pZeoSV (XhoI-PvuII) (Invit r ogen). The pZeoSV plasmid contains the Zeocin antibiotic resistance gene under CMV (euk ary otic) and EM-7 (prokaryotic) promoters. The resultant pZamp vector was then linearized at a unique Xmal restriction enzyme cleavage site within the coding sequence of the Zeo r gene. The linearized vector was incubated with Kienow enzyme to fill in the overlapping bases and then ligated. The resultant vector, pZamp+4 ( Fig. l) . carries a 4-bp insertion that eliminates the Xmal restriction site and is no longer resistant to the 2eocin antibiotic in either prokaryolic or eukaryotic cells. The presence of the ampicillin gene allows for bacterial transformation and selection. Plasmid DNA was prepared by column chromatography (Qiagcn, CA) in accordance with the manufacturer's instructions.
Fragment preparation. Two different DNA fragments, 2eol and Zeo3 (410 and 458 bp. respectively), were employed for targeting ( Fig. 1 ). Both fragments contain the wt 2eo r gene sequence and were prepared by PCR as previously described (8, 11) . Primers ZlBss (5'-GCGCGCGACGTCGCCG GAGCG-3') (sense) and 22 (5'-AACAAGTITCGAGGTCGACCCC-3') (anti sense) were used to generate the 2eol fragment. Primers 23 (5'-TAG GAGGGCCACCATGGCCA-3') (sense) and 22 (antisense) were used for the Zeo3 fragment. The PCR conditions were as follows: initial denaturation, 95°C/2 min; followed by 25 cycles of denaturation, 95°C/5 s; annealing. 65°C/20 s; extension, 72°C/20 s with a 7 min extension in the final cycle. The PCR mixture contained 0.2 rnM dNTPs, 0.2 µM primers, IX DMSO, 1 x Pfu reaction buffer (10 mM KCI, 10 mM (NH 4 ) 2 S0 4 , 20 mM Tris-HCl (pH 8.8), 2 mM MgS0 4 , 0.1% Triton X-100, 100 ng/µI BSA), and I U Pfu DNA polymerase (Stratagene, CA). PCR products were subcloned into the pCR-Script vector (Stratagene), sequenced, and used as a template to gen erate preparative amounts of fragment for transfection. Production of the targeting fragment involved amplification of 1-2 ng of linearized pCRZeol or pCR2eo3 plasmids in a 100-µI PCR mixture containing 0.2 mM dNTPs, 0.2 µM primers, Ix DMSO, 10 mM Tris-HCI, 50 mM KC!, 2 mM MgCl 2 , 0.01 % gelatin, and 2.5 U AmpliTaq polymerase (Perkin-Elmer, CA). PCR products were purified from agarose gel, using the QIAquick II kit (Qia gen). The concentration of the PCR fragments used for targeting was determined using a Gibco BRL DNA mass ladder. DNA fragments were rendered single stranded by heat denaturation at 95°C for 10 min and, unless othe1wise specified, cooled rapidly on ice before transfection.
Experimental protocol. CFBE4 lo-cells were cotransfected with the mutant plasmid (p2amp+4) and DNA fragments under a variety of conditions. These conditions included using DNA fragments of different sizes (2eo 1 or 2eo3), using single-or double-stranded DNA (ssDNA or dsDNA, respec tively), and vaiying the ratios of fragment to mutant plasmid. Successful correction of the mutant sequence was assessed from both trnnsient and stable transfections. For the transient transfections, plasmid DNA was isolated from transfected cells and used to transform bacteria. Correction frequency was determined as the ratio of 2eo r to total Amp r colonies. Control bacterial transformations included mixing extracts from epithelial cells transfected either with mutated plasmids or with DNA fragments alone. Assessment of stable transfections involved selection of epithelial cell clones containing corrected copies of the 2eo' gene. Clones from both lransient and stable transfections were grown and genotypically analyzed by PCR amplification, restriction enzyme cleavage, DNA sequencing, and/or Southern blot hybridization.
Transfection. Cells were transfected with the cationic lipid DOTAP (Boehringer Mannheim), SuperFect (Starburst dendrirner; Qiagen), or clec troporation using different molar ratios of pZamp+4 plasmid and target ing fragments. Cells were grown either on six-well plates (DOTAP and 180 SuperFect) or in T75 flasks (electroporation) until they reached 70-80% confluence.
Briefly, plasmid DNA-DOTAP complexes were formed in 100 µI of scrum-free MEM at a negative to positive charge ratio of 1:4 (3 µg plasmid DNA:27.6 µg DOTAP). Complexes were allowed to form for 20 min and then added to the cells in serum-f r ee medium (1 ml final volume). After 4 h, the medium was replaced with 2 ml of complete medium. Cells were grown at 37°C overnight and again transfected the following day with different amounts of the DNA fragment (heat-denatured ssDNA or unde natured dsDNA) that was complexed with DOTAP at the same charge ratio (1:4) used above. The fragment-DOTAP complex (100 µI) was then added to each well for an additional 4 h in 1 ml of serum-free medium. After washing the cells with Hepes-buffered saline (HBS), 2 ml of complete medium was added to each well. The two transfections were performed on separate days to reduce cytotoxicity. However, a G-h period was sufficient for the cells to recover from transfection-induced stress and gave similar frequenciP.s compared to waiting 12 h before the second transfection (data not shown). Additional experiments using plasmid-DOTAP-fragment complex yielded a correction frequency 10-fold lower than when the transfections were carried out in two steps. Plasmid DNA-SuperFect com plexes were formed using a ratio of 3 µg plasmid DNA:6 µl SuperFect. Different amounts of the DNA fragment-SuperFect complex were then added as described above. Transfections were carried out according to the manufacturer's instructions when using SuperFect or DOTAP.
Electroporation transfections were carried out as described previously (8) . Approximately 10 7 cells were trypsinized, washed with cold PBS (Mg 2+ and Ca 2 + f r ee), and then resuspended in 800 µl of the same PBS solution. From 6 to 18 µg of plasmid DNA (6 µg) was mixed with varying amounts of DNA fragment and added to the cell suspension. The total amount of DNA was kept constant (60 µg) in each set of experiments using carrier DNA (i.e., unrelated fragment). The cell-DNA mixture was then incubated on ice for 10 min and clectroporated at 4°C using a STX 300 Gene Pulser at a setting of 500 µF, 240 mV, and 200 ms in 0.4-cm transfection cuvettes. Cells were incubated on ice for an additional 10 min, diluted 1:20 in complete MEM, and seeded into three T75 flasks.
Analysis of transient transfection. After transfection, cells were cultured at 37°C for 48 -72 h and then hai·vested to isolate plasmid DNA. Briefly, cells were trypsinized and washed once with HBS. Episomal plasmid DNA was extracted using a modified alkaline lysis procedure (19) . When specified, plasmid DNA was also extracted from isolated nuclei (20) . Plasmid DNA was then incubated with RNase A at 37°C for 30 min and loaded onto a 0.7% SeaPlaque low-melting agarose gel. The relaxed and supercoiled forms of the plasmid (Fig. 2) were extracted from the agarose gel with the QIAquickll kit (Qiagcn). A I 0-µl aliquot of each sample was used to transform £. coli DH10B cells by electroporation using a Bio-Rad Gene Pulser II (settings: 25 µF, 200 ohm, and 1800 V; 0.1-cm cuvettes). After a 1-h incubation at 37°C, aliquots of the transformed bacteria cells were plated onto low-salt L-Broth (LB) (pH 7.5) plates supplemented with Zco cin (25 µg/ml) and ampicillin (100 µg/ml) or with ampicillin alone. After an overnight incubation at 37°C. colonies were counted and targeting frequency was determined. The frequency of correction was defined as the number of 2eo r colonies divided by the total number of Amp' colonies in each experiment. The numbers of 2eo' colonies were normalized to correct for variations in plating effi ciency. Individual bacterial clones were ran domly picked and grown overnight in 5 ml LB plus antibiotics. Plasmid DNA was isolated with a Wizard miniprep purification system (Promega. WI). A 200-ng plasmid sample from each clone was digested with Xmal at 25°C and analyzed on a 0.8% agarose gel. In addition, 2 ng of each plasmid sample was used as template for a PCR analysis. The two primers used in the PCR analysis were outside the region of homology defined by the targeting fragment: primer 21 (5'-TACGACTCACTATAGGAGGGCC-3') (sense) and primer 24 (5'-CTACTCAAACCTGTITGGTGTTG-3') (anti sense). The PCR conditions were as follows: initial denaturation. 95°C/2 min; followed by 25 cycles of denaturation, 95°C/5 s; annealing, 60°C/20 s; extension, 72°C/20 s; with a 7-min extension in the final cycle. All PCR amplifications were carried out in a Perkin-Elmer Thermal Cycler (9600). The PCR amplification products (574 bp) were digested with Xmar and analyzed on a 1.8% agarose gel. In addition, an aliquot of the isolated plasmid DNA was sequenced with an ABI 373A sequencer in both direc tions, using primers 21 and 24. Analy sis of stable transfection. After transfection (48 h), the CFBE41o cells were plated into 10-cm dishes and exposed to Zeocin selection (50 µg/ml). Selective medium was replaced with fresh Zeocin-containing me dium every 2 days. Cells were grown until they formed colonies (-100 cells/colony) and isolated using cloning cylinders. Individual clones of Zeo r epithelial cells were subcultured into T75 flasks and grown under continuous selection to 90% confluence. Genomic DNA was isolated from each epithelial cell done and analyzed by PCR and/or Southern blot hybridization. PCR analysis entailed amplification of 200 ng of genomic DNA with Zl and Z4 primers under the conditions described above. The amplification product was digested with Xmal at 25"C and analyzed on a 1.8% agarose gel. Southern blot hybridization analysis involved digesting 10 µg of DNA from individual clones with EcoRI and subsequent electro phoresis on a 0.8% agarose gel in TAE buffer (0.04 M Tris-acetate, 1 mM EDTA). The DNA was transferred from the gel to a nylon membrane (Hybond-N) by capillary action and crosslinked to the membrane using the UV Stratalinker 1800 (Stratagene). Hybridization was performed as previously described (21) at 65°C for 16 h, with two different radioactively randomly labeled probes. The first probe was a 613-bp CMV-specific probe generated by PCR amplification using the same conditions mentioned above with primers CM3, 5'-CATAACTTACGGTAAATGGCCCG-3' (sense), and CMV4, 5'-CGTTCCAATGCACCGTTCCCG-3' (antisense). The first probe was removed by washing the membrane at I oo·c in 0.1 % SDS for 5 min. The second probe, the 410-bp Zeol fragment, was specific for Zeo•· sequences.
RESULTS

Molecular Characterization of Transient Transfection
Targeting frequency was determined from the transient transfection experiments. However. the accuracy of this measurement was dependent on the purification proto col. Due to residual contaminating fragments present in all cell lysates (Fig. 2) , it was necessary to gel purify ex tracted plasmid from the lysates before bacterial transfor mation. If the plasmid is not gel purified, it appears as if the bacteria can facilitate homologous replacement be tween the residual fragment and the defective plasmid after entry into the bacteria (data not shown). Agarose gel analysis of cell lysates also indicated that linear plasmid and genomic DNA were absent and that the extracted plasmid was either in a supercoiled or in a relaxed form (Fig. 2) . Estimates based on comparison to a mass ladder indicated a plasmid recovery between 1 and 2% of the total plasmid DNA transfected.
The presence of an intact Zeo• gene in the extracted plasmids was indicated by the cleavage of plasmid DNA with Xmal (Fig. 3A) , thus showing restoration of the wild type sequences in the mutant pZamp+4 plasmid. Correc tion was also verified through Xmal digestion of the PCR .37 X 10-5 0.87 X 10-5 1 :10 4.93 X 10-5 0.82 X 10-5 1 :30 2.70 X 10-5 0.29 X 10-5 dsZeol 1 :5 4.93 X 10-5 1.39 X 10-5 1 :10 3.57 X 10-5 1.33 X 10-5 None 0 0 SuperFect ssZeol 1 :5 5.93 X 10-5 1.59 X 10-s 1 :10 2.33 X 10-5 0.68 X 10-5 1 :30 2.50 X 10-5 1.30 X 10-5 1 :50 2.73 X 10-5 1.91 X 10-5 1 :60 7.10 X 10-5 1.42 X 10-5 dsZeo1 1 :5 4.47 X 10-s 1.35 X 10-5 1 :10 4.63 X 10-5 0.76 X 10-5 None 0 0 Electroporation ssZeo1 1 :10 2.75 X 10-3 0.42 X 10-3 1:100 1.17 X 10-2 0.24 X 10-2 dsZeo1 1 :10 1.17 X 10-2 0.09 X 10-2 ssZeo3 1 :10 4.07 X 10-2 0.68 X 10-2 None 0 0
Note. SFHR-mediated correction of supercoiled episomal pZamp+4 vector after transient transfections with replacement DNA Fragments. ss, single-stranded fragment; ds, double-stranded fragment.
product after amplification of the plasmid DNA with Zeo' specific primers (Fig. 3B ). Only plasmid isolated from Zeo r bacterial clones showed the expected 458-and 116-bp bands. Finally, the Zeo'" gene in 10 randomly chosen Zeo r bacterial colonies was sequenced in both directions. Re moval of the 4-nt insertional mutation was observed in each case ( Fig. 3C ) and no additional sequence alterations were detected along the entire Zeo' gene. Following transfection of cells with DNA-DOTAP or DNA-SuperFect complexes, targeting frequencies ranging from 1.0 x 10-s to 8.0 x 10-5 were observed ( Table 1 , rows [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . This frequency was independent of the time at which the plasmid was isolated, whether at 48 or at 72 h, after transfection. Neither bacterial-mediated cor rection nor spontaneous reversion was observed (Table 1, rows 6, 14, 19) . In addition, targeting frequency appeared to be independent of the single-or double-sb·anded char acter of the fragment or of the plasmid-to-fragment molar ratio within the range tested. A dramatic 100-to 1000fold improvement in SFHR efficiency was observed when cells were transfected by electroporation ( Table 1 , rows [15] [16] [17] [18] [19] . For example, a targeting f r equency of-0.3% was indicated using the ssZeol fragments at a plasmid-to fragment molar ratio of 1: 10. In subsequent SFHR studies, electroporation was used to further evaluate the effects of the plasmid-to-fragment ratio, fragment length, and frag ment strandedness (ss or dsDNA) on the targeting fre quency. The frequency improved to �1% (a 5-fold im-182 provement) with ssZeol fragments by increasing the plasmid-to-fragment molar ratio to 1: 100. A comparable efficiency (-1 %) was achieved when dsZeo 1 fragments were used and the plasmid-to-fragment ratio was 1: 10 ( Table 1 ). The highest replacement frequency (4%) was observed with ssZeo3 fragments at a plasmid-to-fragment ratio of 1: 10 ( Table 1) .
A potential issue in using artificial vehicles for delivery is that the transfected DNA may be retained in endosomes and other cytoplasmic organelles and not be efficiently transferred into the nucleus (22, 23) . To test whether this was a factor, control studies with wild-type pZamp vectors were carried out. The vector was transfected into cells either via artificial vehicles or by electroporation and then extracted from the cytoplasmic compartment after 48 h. There were abundant Amp'" colonies present in the extract following transfection with artificial vehicle, whereas there were significantly fewer colonies in the extracts following electroporation. This result suggests that intact plasmid is retained in the cytoplasm and possibly pro tected from degradation after b·ansfection with artificial vehicles. Thus, accurate assessment of the targeting fre quency becomes compromised. The total cell lysates will contain Amp\ defective plasmid that has not entered the nucleus and has, therefore, not been accessible to the homologous replacement machinery. To elaborate on this point, further experiments were performed to determine the extent to which the assessment of targeting frequency could be influenced by the presence of cytoplasmic plas mid. In these studies, total cell extracts were compared to nuclear extracts in terms of their relative targeting fre quencies. The frequency increased 100-fold in nuclear lysate compared to the whole-cell lysate from cells trans fected with artificial vehicles ( Table 2 ). There was no dif ference in frequency between the nuclear and the total cell lysates of electroporated cells.
Molecular Characterization of Stable Transfection
In parallel experiments using a plasmid-to-fragment (dsZeol) ratio of 1:10, 20 unique Zeo r epithelial cell clones were isolated by selection in Zeocin-containing medium. The clones were selected after transfection of 4.8 x 10 5 cells with SuperFect. PCR amplification and restriction enzyme digestion (Xmal) of genomic DNA from the Zeo r epithelial clones indicate that these clones contain at least one SFHR-corrected copy of the Zeo r gene giving rise to a minimum correction frequency of 4.1 x 10-s ( Fig. 4 ). In addition, the XmaI digest of the PCR amplicons suggests that both corrected and uncorrected copies of the gene-containing plasmids have integrated into the genomic DNA, because both uncut (574-bp) and cut (458-and 116-bp) products were present (Fig. 4) .
Southern hybridization analysis showed several high molecular-weight bands in individual clones and indi cated the integration of the plasmids into different genomic loci (Fig. 5 ). The absence of bands representing the linear, supercoiled, or relaxed forms of the plasmid further supports the notion that the plasmid(s) has stably integrated. In addition, because the hybridization pat terns using both CMV and Zeo 1 probes were identical, it can be concluded that no random integration of the re placement fragments occurred. This pattern did not change even after the clones were propagated for >50 subcultures.
DISCUSSION
Using the Zeocin-based selection system as a model for SFHR, an optimized targeting frequency of -4% was ob served when the Zeo'· defective plasmid (pZamp+4) was cotransfected into human epithelial cells with single stranded DNA fragments (ssZeo3) of wild-type Zeo r {458 bp) at a ratio of 1:10. The frequency ranged from 0.001 to 4% and was recorded using different SFHR conditions (plasmid-to-fragment ratio, fragment length, and frag ment strandedness (ss-or dsDNA)). These findings are consistent with previous studies evaluating SFHR-medi ated targeting of genomic CFTR sequences that indicated a targeting frequency between 1 and 10% (8) . The target ing frequencies observed in the present study are also comparable to those of studies evaluating site-specific modification of extrachromosomal target genes by small DNA fragments tethered to a triplex-forming oligonucle otide (16) 15 ). In addition, because the maximum correction fre quency measured is four orders of magnitude greater than that associated with classical homologous recombination in human cells (0.0001 %) (1), there is a suggestion that the mechanisms underlying SFHR are, to some degree, independent of and distinct from those involved in clas sical homologous recombination.
The studies presented here demonstrate the sensitivity of the assay system and the SFHR conditions that lead to effective correction. A primary factor influencing the ef ficiency of SFHR-mediated correction appears to be the DNA delivery system. In the present study, electropora tion was 1000-fold more effective for extrachromosomal gene targeting compared to transfection with cationic liposome or dendrimer complexes. These results may, in part, be explained by the observation that uncorrected plasmids were still present in the cytoplasm at least 48 h after transfection using artificial vehicles. This plasmid DNA does not enter the nucleus to undergo SFHR-medi ated exchange and would likely be protected by the de livery vehicle from exonuclease degradation. The defec tive, "cytoplasmic" plasmid component of the whole-cell lysate increases the number of Amp" colonies and thus decreases the actual correction frequency. The 100-fold increase in SFHR frequency observed when bacteria were transformed with plasmid isolated from nuclei alone re inforces this notion and indicates that if plasmid enters the nucleus, the probability of SFHR is increased even when artificial vehicles are used. This artifactual increase in the number of Amp r colonies was not a factor in the electroporation experiments. Following electroporation, there was no significant difference in targeting frequency using plasmids isolated from the nuclear or the whole-cell lysates. In addition, very few functional plasmids were detected in the cytoplasmic fraction 48 h after electropo ration. This is not unexpected, because electroporated DNA is uncoated and is thus more susceptible to degra dation by cytosolic nucleases. Recent studies in COS and HeLa cells support this observation and showed a 50-to 90-min half-life of plasmid DNA when it is directly mi croinjected to the cytoplasm (24) .
The finding, in the electroporation experiments, that dsDNA fragments (dsZeol) were 10-fold more efficient than the corresponding ssDNA fragments (ssZeol) in fa cilitating homologous replacement when the plasmid-to fragment ratio was 1: 10 suggests that different enzymatic pathways mediate SFHR. This finding differs from previ- . . \' · ... . · ,: . . :. , . --�· �Jr. ous studies directed at modifying genomic targets. In these studies either 165-bp DNA fragments or linearized M13 vectors were used, and dsDNA and ssDNA were equally effective in mediating targeted exchange at the genomic hypoxanthine-phosphoribosyltransferase and adenine phosphoribosyltransferase loci, respectively (25. 26) . These studies used DNA-delivery vehicle complexes and showed correction efficiencies of -10-5 to 10-6 . Fur thermore, this discrepancy could, in part, be due to non conservative single-stranded annealing that is distinct f r om the mechanism purported to underlie classical genomic homologous recombination (27) .
While the fragment-to-plasmid ratio appeared to have no dramatic effect in modifying the targeting frequency in cells transfected using artificial delivery vehicles, the studies using electroporation showed a 5-fold increase in targeting when the fragment-to-plasmid ratio was in creased by IO-fold (ssZeol f r agment). The results from the whole-cell extract comparison clearly show that transfec tion with artificial vehicles is complicated by retention and protection of the DNA complex within the cyto plasm. For this reason, electroporation should be used as a standard delivery protocol to obtain measurement of how fragment to plasmid ratio influences targeting effi ciency.
A consideration in using the transient transfection ex pression systems to obtain an accurate quantification of SFHR-mediated correction is the cDNA character of the reporter/selection marker genes used as targets. Because these assay systems are composed of cDNA, no intron sequences are present in the replacement fragments. This could result in an underassessment of the targeting effi ciency, because SFHR-mediated correction could intro duce inactivating mutations into the coding region when the ends of the targeting fragments are within exons (28, 29) . Fortunately. the small size (374 bp) of the selection gene chosen in our system has facilitated some degree of elucidation of this possibility. Of the two different re placement fragments, Zeal and Zeo3, only Zeo3 has both 5' and 3' ends outside of the coding region of the Zeo' gene. It is, thus, possible that having the ends of the fragment outside the coding region, and the placement of the modifying sequences in a more central position within the replacement fragment, results in an increase the targeting frequency from 0.3 to 4%. This frequency is comparable to values obtained in correction of genomic CFTR DNA (8) and implies that SFHR-mediated modifica tion of genomic DNA and extrachromosomal DNA may engage elements that are similar.
Finally, the selective nature of this assay system allowed for the isolation of individual Zeo .. epithelial cell clones. Southern hybridization analysis of these isogenic clonal cell populations showed a heritable integration of the plasmids for >SO subcultures. More importantly, this analysis revealed no random integration of the correcting fragments after SFHR, addressing a very relevant concern about the safety of SFHR-mediated gene targeting.
In summary, the Zeocin system has provided an effec tive means to accurately quantify and characterize SFHR-184 mediated correction. The findings of the present study support our previous results (8, 10) and have provided insight into the conditions that modulate SFHR and the pathways that underlie SFHR-mediated targeting. Varying the conditions relevant to SFHR, such as the delivery systems, and/or the length and character of the DNA fragments has been shown to influence gene targeting and can be further optimized to improve the efficiency of SFHR. SFHR appears sequence independent and can si multaneously add or delete multiple nucleotides whether or not they are adjacent. Thus, SFHR can complement other gene targeting strategies that are limited either to specific sequences or to the number of bases that can be simultaneously modified (1, 2) .
